In view of the high response rates (ie, up to 60% partial remissions) achieved in advanced cervical cancer with mitomycin C-vincristine-bleomycin and bleomycin methotrexate, the poor results of our study suggest that the adriamycin-cyclophosphamide combination has no important role in the treatment of this disease.
|Original language||English (US)|
|Number of pages||2|
|Journal||Cancer Treatment Reports|
|State||Published - Jan 1 1978|
ASJC Scopus subject areas
- Cancer Research